Rimei Nishimura
Overview
Explore the profile of Rimei Nishimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
1471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, et al.
J Diabetes Investig
. 2024 Jul;
15(9):1326-1342.
PMID: 38988282
This algorithm was issued for the appropriate use of drugs for the treatment of type 2 diabetes mellitus in Japan. The revisions include safety considerations, fatty liver disease as a...
12.
Sugawara Y, Kanda E, Hamano T, Itano S, Okada H, Tomori K, et al.
Clin Exp Nephrol
. 2024 Jul;
28(9):847-865.
PMID: 38970650
Background: For the development of pharmaceutical products in kidney field, appropriate surrogate endpoints which can predict long-term prognosis are needed as an alternative to hard endpoints, such as end-stage kidney...
13.
Matoba K, Nagai Y, Sekiguchi K, Ohashi S, Mitsuyoshi E, Shimoda M, et al.
Commun Biol
. 2024 Apr;
7(1):402.
PMID: 38565675
Focal segmental glomerulosclerosis (FSGS) shares podocyte damage as an essential pathological finding. Several mechanisms underlying podocyte injury have been proposed, but many important questions remain. Rho-associated, coiled-coil-containing protein kinase 2...
14.
Nishimura R, Shimada A, Abiru N, Matsuhisa M, Takahashi Y, Ikegami H
Diabetol Int
. 2024 Mar;
15(2):212-222.
PMID: 38524926
Aims/introduction: Psychosocial aspects and the quality of life (QOL) of individuals with diabetes are important for achieving glycemic control and treatment goals. Here, we describe patient-reported outcomes (PROs) of Japanese...
15.
Exploring time in tight range targets (TITR) in drug-naive Japanese individuals with type 2 diabetes
Ishiguro M, Ando K, Nishimura R
Acta Diabetol
. 2024 Mar;
61(7):933-936.
PMID: 38502327
No abstract available.
16.
Takahashi H, Suganuma Y, Ohno T, Nishimura R
Diabetol Int
. 2024 Jan;
15(1):141.
PMID: 38264230
[This corrects the article DOI: 10.1007/s13340-022-00577-y.].
17.
Kamiya H, Himeno T, Watarai A, Baba M, Nishimura R, Tajima N, et al.
Diabetol Int
. 2024 Jan;
15(1):19-27.
PMID: 38264223
Aim/introduction: This study aims to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in patients with type 2 diabetes registered in the Japan Diabetes Complication and its...
18.
Goto A, Ohashi K, Noda M, Noto H, Ueki K, Inoue M, et al.
Diabetol Int
. 2024 Jan;
15(1):5-18.
PMID: 38264218
The Japan Diabetes Society (JDS) and the Japan Cancer Association (JCA) launched a joint committee and published their "First Joint Committee Report on Diabetes and Cancer" in 2013, compiling recommendations...
19.
Kamiya H, Himeno T, Watarai A, Baba M, Nishimura R, Tajima N, et al.
J Diabetes Investig
. 2024 Jan;
15(2):247-253.
PMID: 38213265
This study aimed to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in patients with type 2 diabetes registered in the Japan Diabetes Complication and its Prevention...
20.
Goto A, Ohashi K, Noda M, Noto H, Ueki K, Inoue M, et al.
Cancer Sci
. 2024 Jan;
115(2):672-681.
PMID: 38184804
The Japan Diabetes Society and the Japan Cancer Association launched a joint committee and published their "First Joint Committee Report on Diabetes and Cancer" in 2013, compiling recommendations for physicians...